Professional Documents
Culture Documents
Pocket Pedia PDF
Pocket Pedia PDF
CEPHALOSPHORINS
Compression Approximately 1/3 Approximately Approximately 1st GENERATION
depth to ½ depth of 1/3 to ½ depth of 1/3 to ½ depth of
Cephalexin TD: 30-50 mg/k/d q6-8 (keflex)
chest chest chest
monohydrate OM: 75-100 mg/k/d 100mg/ml drops
125mg/5ml susp,
Compression 100/min >100min 120 events/min
250mg/5ml susp
rate ( 90
250, 500 mg 1 g cap
compressions /30
250, 500 mg pulvule
breaths)
Cefalothin Na 80-160 mg/k/d q 6h 1g/vial
life threatening: up to 2g/k/d q4 (Keflin)
Compression 5:1 ( pause for 5:1 ( pause for 3 :1
ventilation ration ventilation until ventilation until Cefazolin NB: 40mg/k/d q 12 (1st wk) (Stancef)
trachea is trachea is 40-60mg/k/d q8-12 (1-4 wks) 500mg &
intubated) intubated) IM/IV over 15-30 min 1 g vials
IN,CH: 50-100mg/k/d q8 IM/IV
2nd GENERATION
Cefaclor IN,CH: 20-40mg/kg/day po q8 250, 500 mg cap
(ceclor) A: 750mg-1.5g q8 125mg/5 ml susp
250mg/5 ml susp
Cefuroxime 100-150 mg/kg/d q8 IM/IV Zinacef:
PENICILLINS 10-15 mkday q12 oral 250mg, 750mg,
Amoxicillin 30-50 mg/kg/day q 8 po 250,500mg cap 250mg/kg/d q 6 IV (for bacterial 1.5g vial; 125mg/ml
(Amoxil, 100mg/ml drops meningitis) susp
Himox, 125, 250mg/5ml susp OM: 40mg/k/d q 12 125mg, 250mg,
Jamox) (Moxicillin, pediamox, >5 yrs: 30 mkd q 12 500mg tab
sumoxil,wyamox) >5 yrs: 40 mkd q 12 Zinnat: 125, 250mg
Amoxicillin- 30-50mg/kg/day q8 IV,PO Syrup: TID A: 250mg q 12 sachet susp.,
Clavulanic 156mg/5ml (125mg 125mg, 250mg,
Acid amox) 500mg coated tab
or Co- 312mg/5ml (250mg Cefetamet CH<12 yrs: 10 mg/kg q 12 (globocef)
amoxiclav amox) >12 yrs: 500 mg po q 12 250, 500 mg tab
Cap: 250mg/5ml susp
375mg/tab (250mg Cefoperazone CH: 100-150mg/k/d q 6-8 (cefobis)
amox) IM/IV 500 mg, 1 g vials
625mg/tab (500mg A: 2-12g/d IM/IV q 6-8
amox) Cefotaxime IN,CH: 50-100mg/k/d q 12-16h (Claforan)
Vail: A (gonorrhea): 500mg IM/IV SD 250mg, 500mg, 1 g
300mg/vial (250mg vial
amox)
500mg/vial (500mg Cefoxitin 80-160 mg/kg/day IM/IV q 4-8 (Mefoxin) 1 g vial
amox)
1.2g/vial (1g amox) 3rd GENERATION
Syrup BID Ceftriaxone 50-100mg/kg/day q12-24 IV (Rocephin)
457 mg/5ml (4oo mg (3rd gen) Typhoid:75-80mg/kg/day x IM: 250mg, 500mg,
amox) 228.5 mg/5 ml ( A: 1-4 g/d 1 g (inj. w/ lidocaine)
200 mg amox IV: 250mg, 500mg,
1 g (inj. w/ 1%
Ampicillin NB: 50-100 mkd q 6-8 IM/IV Syrup: water)
(Ampedia, (up to 1 wk) 125mg/5ml, 250mg/ml Ceftazidime NB<2000g: 100mg/k/d q12 (Fortum)
Ampicin) 100-200mg/k/d q8 (1-4 wk) cap:250mg, 500mg (3rd gen) (up to 1 week) 250mg,500mg
IN,CH: 100-200 mkd q 4-6 IM/IV vial: 100,125,500mg/vial 150mg/k/d q8 (1-4 wk) 1g, 2g vials
CH: 100-150 mg/kg/day q 8
Ampicillin- Ampi 250mg + cloxa 250 mg 250 mg cap A: 1-6 g/d q8 IM/IV
Cloxacillin Same as ampicillin 250mg/5ml syrup Cefixime 3-8 mkday q 12 Drops:20mg/ml
(pensyclox,Am 75, 250, 500 mg vial ( Tergecef Susp:100mg/5ml
piclox,Cloxami Drops:A60mg + C 30mg q 6 Zefral, Cap:100mg, 200mg
cin) Infant vials: A50mg + C25mg q8 Ultraxime)
Ceftizoxime (3rd CH: 40-80 mg/k/d q 6-12 (Tergecin) Strepto CH: 20-40mg/kg/d qd IM x 2mos 1 g vial
gen) A: 500mg-2g/d q 6-12h IM/IV 500mg mycin (max 1 g/d)
1 g vials 25 A: 15-25 mg/kg/d or 1 g daily,
Cefotaxime 100-200mg/kg/day q6-8 IV 250mg, 500mg, qd, IM
1g/vial Cloforan
Ceftazidime 90-150mg/kg/day q8 IV 250mg, 500mg, COLDS PREPARATION:
1g/vial Fortum
Phenylpropanolamine 1-3mos: ¼ ml q 8 Disudrin
MACROLIDES (decongestant) 4-6mos: ½ ml q 8 12.5mg/5ml syr
Azithromycin CH: 10mg/kg/day x 3 days or 250mg cap 7-12 mos: ¾ ml q 8 6.25 mg/ml drops
alternatively for 5 days w/ a 200mg/5ml powder 1-2 yr: 1 ml q 8
single 10mg/kg dose on day 1 for oral suspension 2-6 yr: ½ tsp q 8
then 5 mg/kg on D2-5 7-12 yr: 1 tsp q 8
Clarithromycin CH: 15mg/kg q12 po (Klaricid) 250mg tab Combined Prep: Rondec, Drixine, Sudafed, Dimetapp, Decolsin, Triaminic,
A: 500-1000 mg q12 125mg/5ml susp Tridecon
Severe infxn: 2 tab BID x 6-14 Brompheneramine 1-3 mos: 0.25 cc Dimetapp
days maleate, phenylephrine, 4-6 mos: 0.5 cc Per 5 ml syrup
Erythromycin IN,CH: 30-50mg/kg/day q6 (Erycin, Macrodin, phenylpropanolamine 7mos-2 yrs: 1 cc Per infant drop
po Ilosone 3-12 yrs: 1 tsp TID
15-30mg/k/d q6 SIV 125mg/5ml;
infusion 250mg/5ml) Iron Supplement
A: 1-2 g/k/d q6 po 100mg/2.5ml drops Dose: 3-5 mg/kg/day (maintenance)
1-4gkd q6 IV 250mg, 500mg cap 6 mg/kg/day ( therapeutic dose)
Int. antisepsis: 1 g/dose x 3 200mg/5ml susp preparation: drops 15 mg/ml
doses (1pm,2pm, 11pm) the day 400mg/5ml susp syrup 30 mg/5 ml
before sx 500 mg vial
Roxithromycin A: 1 tab BID po 15-30 min before
Immuzinc
(Rulid, Macrol) meals
dose: 1-2 mg/kg/day
QUINOLONES
prep: 20 mg /5 ml syrup
Ciprofloxacin A: 500mg-1.5 g po q12 10 mg/ml drops
(Ciprobay) 100-200 mg as IV infusion for
30 min q12 Nifuroxazide (ercefuryl)
Norfolxacin UTI: 200-400 mg BID < 6 monts 1 tsp BID
GI infxn: 400 mg BID > 6 months 1 tsp TID
Gonorrhea: 800mg SD
Ofloxacin Inoflox, Qinolon Calcium Gluconate
Uncom. UTI 100mg BID po x 2-7 days Dose: 200-300
Compl. UTI, Pn, 200mg BID po x 7-14 days 100, 200mg tab Ex. WT x dose x prep
OM, sinusitis, skin 1.4 kg x 200 mg/ml = 290 mg/ml x 100mg /ml
& soft tissue infxn = 2.9 ml
Gonococcus
Non- 300-600mg as single dose Naloxone
gonococcus 100-200mg BID x 7-14 days Dose: 0.1 mg/kg/dose IV/IM/SC
GI infection
200-300mg BID x 5-7 days Theophylline
prep: 80 mg/ml
26.7 mg/ml
dose: 2.5 mg/kg/dose q12
ANTI-VERTIGO
Betahistine A: 1-2 tab TID po with meals Serc, mension
6mg tab (mesylate)
8, 16 mg tab
(dihydrochloride)
Meclezine HCl 12.5-50 mg/k/day TID/BID Bonamine 25 mg tab
<6 mos: 0.5 ml daily Bonadoxine 8 mg/ml
2-6 yrs: 3 ml or drops
1-2 tabs daily
Weight
DEVELOPMENTAL MILESTONES IBW kg
Age Gross Motor Visual- Language Social/Adaptive preterm (# of days -14) x 15 + BW 9gms
Motor/Problem term (# of days -10 x 20 + BW 9 grms
Solving At birth 3.25
1 mo Raises head Birth: Visually Alerts to sound Regards face 3-12 mo Age in months + 9
from prone fixes 2
position 1-6y/o (age in yrs x 2) + 8
1 mo: Has tight 7-12 y/o (age in yrs x 7) – 5
grasp, follows to 2
midline
2 mo Holds head in No longer Smiles socially Recognizes Length
midline, lifts clenches fists (after being parent Ave BL 50 cm (20 in)
chest off table tightly, follows stroked or talked 1 y/o 75 cm
object past to) 3y/o 3 ft.
midline 4y/o BL x 2
3 mo Supports on Holds hands Coos (produces Reaches for >2y/o (age in yrs x 5) + 80
forearms in open at rest, long vowel sounds familiar people or
prone position, follows in circular in musical fashion) objects,
holds head up fashion, anticipates
steadily responds to feeding
visual threat
4 mo Rolls over, Reaches with Laughs, orients to Enjoys looking
supports on arms in unison, voice around
wrists, and brings hands to
shifts weight midline
6 mo Sits Unilateral reach, Babbles, ah-goo, Recognizes that
unsupported, uses raking razz, lateral someone is a
puts feet in grasp, transfers orientation to bell stranger
mouth in objects
= WBC (% neutrophils + % bands) x 1000
Holiday Segar
BW (kg) Fluid volume
1-10 y/o 100 ml/kg
11-20 1000 ml+ 50 ml/kg for each kg > 10kg
>20 1500+ 20 ml/kg for each kg > 20 kg
Fluid Balance
Ludans method <15 kg >15 kg
<2 y/o >2 kg TFB=Total fluid intake – total fluid output
TFI – ( TFO + (BSAxIWL))
mild 50 30
TFI = parenteral (IVF/meds) + oral
moderate 100 60 TFO= IWL (400-700/m2) + urine output+ vomitus/ NGT output
¼ PLR ¾ D50.9 6-7 hrs TFR = BSA x IWL + ½ U.O in 24 hours(if with diuretics )
severe 150 90 If w/o diuretic use BSA x IWL + U.O in 24 hours
1/3 PLR x 1 hr
2/3 D5 0.3 or 0.9 6-7hrs
For every degree rise in temperature add 12% Of maintenance
Aminosteril Feeding
Blood Transfusion
score
ABG Respi. Stridor none 0
audible stridor 1
pH 7.35- 7.45 when agitated 2
pCO2 35-45 at rest 3
pO2 80-100 severe 4
HCO3 22-26 Cough none 0
O2sat 94- 100%
when agitated 1
BE +/- 2
croup like at rest 2
Urine Anion Gap severe 3
= urine Na + Urine K – U Cl - U HCO3 retraction rest 0
(+) = low H+ secretion and low ammonium excretion mild 1
(-) = urinary bicarbonate loss moderate 2
severe 3
Nutrition Dyspnea none 0
TCR = IBW x RDA for age or mild 1
TCR = holiday segar method (in kcal/kg) moderate 2
CHON : 2 gm/kg/day severe 3
Fats: 40% color normal 0
CHO: 60 % cyanosis at room air 1
divided into 3 meals and 3 snacks cyanosis w/02 2
Intralipid
WT. x 0.5 /kg = x (gm)
x (g) x 100 ml/10 gm = x (cc)
Hypoxic Ischemic Encephalorathy (Sarnat Scoring)
To order: start intralipid 10% give __ cc
to run for 1 hr. (as test dose) then 14 cc to I II III
run for 20 hrs via infusion/syringe pump level of conciusness alert lethargy coma
* insert another line muscle tone normal or hypertonic hypotonic failed
* intralipid should not be mixed with electrolyte containing IVF myoclonus + + -
Lipid seizure - + +
Dose: 0.5 - 2 suck reflex active weak absent
Wt x dose x 100/ 20 (if 20% prep) moro reflex exagerated inc. -
* add additional amount of D5W total of 24 cc to run at 1 cc/hr for 24 hrs via syringe grasp N or inc exag. -
pump
dolls eye N overactivity dec. 0r -
* wrap tubing with carbon paper
respi. reg. varies apneic
Gomez Classification CR N or tachy brady brady
Actual wt. x 100% pupils dilated reactive aniso aniso
Ht. for age reactive nonreact.
97-100% normal
st TABLE 25-3 -- EVALUATION OF CEREBROSPINAL FLUID
76-96% 1 deg. Mal.
nd
61-75% 2 Deg. Mal WBC Count Mean % PMNs
rd 3
<60% 3 deg mal. Preterm 0–25 WBCs/mm 57%
3
Term 0–22 WBCs/mm 61%
3
Child 0–7 WBCs/mm 5%
Waterlowe Classification
Ex. BW = 3 kg TABLE 17-3 -- PREDICTED ENDOTRACHEAL TUBE SIZE AND EXPECTED BIRTH
*
3 x 2 ml = 6 ml WEIGHT BY GESTATIONAL AGE
6 x factor = 6 x 0.11 Gestational Weight ETT Size (mm) ETT Depth of Insertion
= 0.66 cc Age (wk) (g) (cm from upper lip)
order: 5.3 cc of present IVF (or D5W) + 0.7 cc of D50-50 to make D10 as bolus 24 700 2.5 7
26 900 2.5 7
28 1100 2.5–3.0 7
30 1350 3.0 7
32 1650 3.0 7
34 2100 3.5 8
36 2600 3.5 8
38 3000 3.5–4.0 9
TABLE 17-11 -- GUIDELINES FOR USE OF PHOTOTHERAPY IN PRETERM INFANTS <1 Pulse Cyclophosphamide Therapy
WEEK OF AGE ( for Systemic Lupus Erythematosus)
Weight (g) Phototherapy (mg/dL) Transfusion (mg/dL) Pre hydration:
Consider Exchange - D5W 750 ml to run for 1 hour alternate with D5 0.3 Nacl 750 ml to run for 1 hour
500–1000 5–7 12–15 for 2 doses
1000–1500 7–10 15–18 - Ondansetron (zafran) 8 mg/4ml, 4 mg +50 ml D5W to run for 30 mins
1500–2500 10–15 18–20 - cyclphophamide 1gm (1000 mg) + 100 ml D5W to run for 1 hour
>2500 >15 >20
Post chemo/ cyclophosphamide hydration
GUIDELINES FOR USE OF PHOTOTHERAPY IN PRETERM INFANTS <1 WEEK OF AGE - same regulation as pre chemo hydration
Weight (g) Phototherapy Transfusion (mg/dL) Consider Exchange - ondansetron 4mg + 50 ml D5W for 30mins
(mg/dL) - Prednisone 20 mg OD after breakfast
500–1000 5–7 12–15 - TPR q4 and record pls.
- I and O q shift
1000–1500 7–10 15–18
- limit sodium intake to 2 g/day
1500–2500 10–15 18–20 - maintain on heplock after 10 hrs. therapy
>2500 >15 >20
Materials for Triple Intrathecal (TIT)
ALDOLASE
(Major sources: skeletal muscle and myocardium)
10–24 mo 3.4–11.8 U/L 3.4–11.8 U/L
2–16 yr 1.2–8.8 U/L 1.2–8.8 U/L
Lumbar Tap Orders Adult 1.7–4.9 U/L 1.7–4.9 U/L
Please secure consent
Prepare the ff materials: ALKALINE PHOSPHATASE
Sterile gloves size _____ (Major sources: liver, bone, intestinal mucosa, placenta, and kidney)
Disposable needle q 23/24 Infant 150–420 U/L 150–420 U/L
Sterile Specimen bottles #4
2–10 yr 100–320 U/L 100–320 U/L
Eye sheet
Sterile gauze/cotton Adolescent males 100–390 U/L 100–390 U/L
Betadine/Alcohol #1 Adolescent females 100–320 U/L 100–320 U/L
Secure ___________ for sedation Adult 30–120 U/L 30–120 U/L
For HGT prior to LT
IRON
BILIRUBIN (TOTAL) Newborn 100–250 μg/dL 17.9–44.8 μmol/L
Cord Infant 40–100 μg/dL 7.2–17.9 μmol/L
Child 50–120 μg/dL 9.0–21.5 μmol/L
Preterm <2 mg/dL <34 μmol/L Adult male 65–175 μg/dL 11.6–31.3 μmol/L
Term <2 mg/dL <34 μmol/L Adult female 50–170 μg/dL 9.0–30.4 μmol/L
0–1 days
Preterm <8 mg/dL <137 μmol/L
Term <8.7 mg/dL <149 μmol/L Conventional Units Sl Units
MAGNESIUM 1.3–2.0 mEq/L 0.65–1.0 mmol/L
1–2 days
METHEMOGLOBIN <1.5% total Hgb
Preterm <12 mg/dL <205 μmol/L OSMOLALITY 275–295 mOsm/kg 275–295 mmol/kg
Term <11.5 mg/dL <197 μmol/L
3–5 days
Preterm <16 mg/dL <274 μmol/L
KETONES (SERUM)
Term <12 mg/dL <205 μmol/L
Quantitative 0.5–3.0 mg/dL 5–30 mg/L
Older infant
Preterm <2 mg/dL <34 μmol/L LACTATE
Capillary blood
Term <1.2 mg/dL <21 μmol/L
Newborn <27 mg/dL 0.0–3.0 mmol/L
Adult 0.3–1.2 mg/dL 5–21 μmol/L Child 5–20 mg/dL 0.56–2.25 mmol/L
BILIRUBIN (CONJUGATED) Venous 5–20 mg/dL 0.5–2.2 mmol/L
Arterial 5–14 mg/dL 0.5–1.6 mmol/L
Neonate <0.6 mg/dL <10 μmol/L
Infants/children <0.2 mg/dL <3.4 μmol/L LACTATE DEHYDROGENASE (AT 37°C)
(Major sources: myocardium, liver, skeletal muscle, erythrocytes, platelets, and lymph
CALCIUM (TOTAL) nodes)
Preterm 6.2–11 mg/dL 1.6–2.8 mmol/L 0–4 days 290–775 U/L 290–775 U/L
Full term <10 days 7.6–10.4 mg/dL 1.9–2.6 mmol/L 4–10 days 545–2000 U/L 545–2000 U/L
10 days–24 mo 9.0–11.0 mg/dL 2.3–2.8 mmol/L 10 days–24 mo 180–430 U/L 180–430 U/L
2–12 yr 8.8–10.8 mg/dL 2.2–2.7 mmol/L 24 mo–12 yr 110–295 U/L 110–295 U/L
Adult 8.6–10 mg/dL 2.2–2.5 mmol/L >12 yr 100–190 U/L 100–190 U/L
LIPASE
0–90 days 10–85 U/L
3–12 mo 9–128 U/L
1–11 yr 10–150 U/L
>11 yr 10–220 U/L
CHOLESTEROL
(see Lipids)
C-REACTIVE PROTEIN
(Other laboratories may have different 0–0.5 mg/dL
reference values)
CREATINE KINASE (CREATINE PHOSPHOKINASE)
(Major sources: myocardium, skeletal muscle, smooth muscle, and brain)
Newborn 10–200 U/L 10–200 U/L
Man 15–105 U/L 15–105 U/L
Woman 10–80 U/L 10–80 U/L PHENYLALANINE
Preterm 2.0–7.5 mg/dL 121–454 μmol/L
Newborn 1.2–3.4 mg/dL 73–206 μmol/L
Adult 0.8–1.8 mg/dL 48–109 μmol/L
CREATININE (SERUM)
Cord 0.6–1.2 mg/dL 53–106 μmol/L PHOSPHORUS
Newborn 0.3–1.0 mg/dL 27–88 μmol/L Newborn 4.5–9.0 mg/dL 1.45–2.91 mmol/L
Infant 0.2–0.4 mg/dL 18–35 μmol/L 10 days–24 mo 4.5–6.7 mg/dL 1.45–2.16 mmol/L
Child 0.3–0.7 mg/dL 27–62 μmol/L 24 mo–12 yr 4.5–5.5 mg/dL 1.45–1.78 mmol/L
Adolescent 0.5–1.0 mg/dL 44–88 μmol/L >12 yr 2.7–4.5 mg/dL 0.87–1.45 mmol/L
Man 0.7–1.3 mg/dL 62–115 μmol/L
Woman 0.6–1.1 mg/dL 53–97 μmol/L POTASSIUM
Newborn 3.7–5.9 mEq/L 3.7–5.9 mmol/L
ERYTHROCYTE SEDIMENTATION RATE (ESR) Infant 4.1–5.3 mEq/L 4.1–5.3 mmol/L
Term neonate 0–4 mm/hr Child 3.4–4.7 mEq/L 3.4–4.7 mmol/L
Child 4–20 mm/hr Adult 3.5–5.1 mEq/L 3.5–5.1 mmol/L
Adult (male) 1–15 mm/hr
Adult (female) 4–25 mm/hr PREALBUMIN
Newborn 7–39 mg/dL
1–6 mo 8–34 mg/dL
6 mo–4 yr 2–36 mg/dL
4–6 yr 12–30 mg/dL
FERRITIN
6–19 yr 12–42 mg/dL
Newborn 25–200 ng/mL 20–200 ng/mL
1 mo 200–600 ng/mL 200–600 ng/mL
Conventional Units Sl Units
2–5 mo 50–200 ng/mL 50–200 ng/mL
PYRUVATE 0.3–0.9 mg/dL 0.03–0.10 mmol/L
6 mo–15 yr 7–140 ng/mL 7–140 ng/mL
RHEUMATOID <30 U/mL
Adult male 20–250 ng/mL 20–250 ng/mL FACTOR
Adult female 10–120 ng/mL 10–120 ng/mL
SODIUM
FOLATE (SERUM) Preterm 130–140 mEq/L 130–140 mmol/L
Newborn 5–65 ng/mL 11–147 nmol/L Older 133–146 mEq/L 133–146 mmol/L
Infant 15–55 ng/mL 34–125 nmol/L
2–16 yr 5–21 ng/mL 11–48 nmol/L
>16 yr 3–20 ng/mL 7–45 nmol/L TOTAL IRON-BINDING CAPACITY (TIBC)
Infant 100–400 μg/dL 17.9–71.6 μmol/L
γ-GLUTAMYL TRANSFERASE (GGT) Adult 250–425 μg/dL 44.8–76.1 μmol/L
(Major sources: liver [biliary tree] and kidney)
Cord 19–270 U/L 19–270 U/L TRANSFERRIN
Preterm 56–233 U/L 56–233 U/L Newborn 130–275 mg/dL 1.30–2.75 g/L
0–3 wk 0–130 U/L 0–130 U/L 3 mo–10 yr 203–360 mg/dL 2.03–3.6 g/L
3 wk–3 mo 4–120 U/L 4–120 U/L Adult 215–380 mg/dL 2.15–3.8 g/L
3–12 mo boy 5–65 U/L 5–65 U/L
3–12 mo girl 5–35 U/L 5–35 U/L
1–15 yr 0–23 U/L 0–23 U/L UREA NITROGEN
Adult male 11–50 U/L 11–50 U/L Premature (<1 week) 3–25 mg/dL 1.1–8.9 mmol/L
Adult female 7–32 U/L 7–32 U/L
Newborn 4–12 mg/dL 1.4–4.3 mmol/L
GLUCOSE (SERUM) Infant/child 5–18 mg/dL 1.8–6.4 mmol/L
Preterm 20–60 mg/dL 1.1–3.3 mmol/L
Newborn, <1 day 40–60 mg/dL 2.2–3.3 mmol/L
Adult 6–20 mg/dL 2.1–7.1 mmol/L
URIC ACID
0–2 yr 2.4–6.4 mg/dL 0.14–0.38 mmol/L
VITAMIN A
(Retinol)
VITAMIN B1
(Thiamine) 5.3–7.9 μg/dL 0.16–0.23 μmol/L
VITAMIN B2
(Riboflavin) 4–24 μg/dL 106–638 nmol/L
VITAMIN B12
(Cobalamin)
VITAMIN C
(Ascorbic acid) 0.4–1.5 mg/dL 23–85 μmol/L
VITAMIN D3
(1,25-dihydroxy-vitamin 16–65 pg/mL 42–169 pmol/L
D)
VITAMIN E
<11 yr 3–15 mg/L 7.0–35 μmol/L
ZINC
Age Wbc
Birth 9-30
12 hrs 13-38
24 hrs 9.4-34
1 wk 5-21
2 wk 5-20
1 mo 5-19.5
6 mo 6-17.5
1 yrs 6-17.5
2 yrs 6-17
4 yrs 5.5-15.5
6 yrs 5-14.5
8 yrs 4.5-13.5
10 yrs 4.5-13.5
16 yrs 4.5-13
21 yrs 4.5-11